Vaxart, Inc. — Form D/A
Vaxart, Inc. of SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2012-06-29. The offering totals $16.9M, of which $16.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2012-06-29
- Form: D/A
- Accession: 0001480950-12-000003
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $16.9M
- Amount sold: $16.9M
- Remaining: $6
- Investors: 11
- Date of first sale: 2009-12-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-137854
Issuer
- Name: Vaxart, Inc.
- CIK: 0001480950
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 20 CALIFORNIA STREET, 7TH FLOOR, SAN FRANCISCO, CA, 94111
- Phone: 415-437-0132
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| John Cornwell | Executive Officer | Parsippany, NJ |
| David Liebowitz | Executive Officer | New York, NY |
| Michael Finney | Director | Beverly, MA |
| Michael Finney | Executive Officer | Beverly, MA |
| David Madden | Executive Officer | MARIETTA, GA |
| Richard Markham | Director | Raleigh, NC |
| Wouter Latour | Director | SAN FRANCISCO, CA |
| Wouter Latour | Executive Officer | SAN FRANCISCO, CA |
| Sean Tucker | Director | SAN FRANCISCO, CA |
| Sean Tucker | Executive Officer | SAN FRANCISCO, CA |
| Jan Leschly | Director | SAN FRANCISCO, CA |
Other filings by this issuer (2)
More